Physician profile
Connie Chein
NPI 1851327431
$2,062.28
in general payments reported to CMS, 2019-2025
19 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $380 · 2021: $501 · 2022: $337 · 2023: $296 · 2024: $143 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $473.06 | 2019-2022 | |
| Abbvie INC. | $462.55 | 2020-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $243.95 | 2021-2025 | |
| Exeltis, USA INC. | $225.25 | 2019-2025 | Slynd, Solosec |
| Shield Therapeutics INC | $153.29 | 2022-2025 | Accrufer |
| Exact Sciences Corporation | $72.90 | 2023-2025 | Cologuard Collection Kit |
| Ascend Therapeutics US, LLC | $58.94 | 2020-2021 | |
| Avion Pharmaceuticals | $58.13 | 2021-2022 | |
| Allergan, INC. | $48.50 | 2020 | |
| Roche Diagnostics Corporation | $47.22 | 2019-2020 | |
| Evofem Biosciences, INC. | $39.98 | 2021 | |
| Amgen INC. | $29.58 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.47 | 2022 | |
| Vertical Pharmaceuticals, LLC | $24.30 | 2019 | |
| Ibsa Pharma INC. | $23.84 | 2023 | Tirosint, Licart |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.23 | 2019 | |
| Aspira Women'S Health INC | $19.82 | 2023 | Ova1 |
| Lupin INC. | $17.25 | 2020 | |
| Myovant Sciences INC. | $17.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Chein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.